• A
• B
• C
• D
• E
• F
• G
• H
• I
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Atezolizumab (Tecentriq®) for 1L NSCLC. HTA ID: 21012

Atezolizumab (Tecentriq®) for triple-negative breast cancer.

Atezolizumab (Tecentriq®) HTA ID: 20039

Atezolizumab (Tecentriq®) in combination with bevacizumab. HTA ID: 20060

Atezolizumab (Tecentriq®) in combination with carboplatin and etoposide for 1L ES-SCLC HTA ID: 19030

Autologous anti-CD19-transduced CD3+ cells (Tecartus®). HTA ID: 21005

Avanafil (Spedra®)

Avatrombopag (Doptelet®). HTA ID: 20006

Avatrombopag (Doptelet®). HTA ID: 20058

Avelumab (Bavencio®)